InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (6 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
6
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the detailed record of transactions filed by Cole Jason, Chief Operating and. Insider active across 1 company, notably bluebird bio, Inc.. In total, 12 reports have been published. Split: 0 buy · 6 sells. Total volume traded: €137k. History available since 3 May 2021. The latest transaction was disclosed on 19 August 2022 (Cession). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations12 total
14,194 shares@ US$5.528656.8% of flowCommon StockSEC:0001562180-22-006290:0
7,448 shares@ US$4.391423.3% of flowCommon StockSEC:0001562180-22-005941:0
25,000 shares0Common StockSEC:0001562180-22-001083:0
25,000 shares0Common StockSEC:0001562180-22-001083
1,584 shares@ US$9.4022100.0% of flowCommon StockSEC:0001562180-22-000443
1,584 shares@ US$9.402248.3% of flowCommon StockSEC:0001562180-22-000443:0
1,539 shares0Common StockSEC:0001628280-21-023652:0
1,539 shares0Common StockSEC:0001628280-21-023652
32,266 shares0Common StockSEC:0001562180-21-005171
32,266 shares0Common StockSEC:0001562180-21-005171:0
38 sharesCommon StockSEC:0001562180-21-003230
38 shares@ US$30.15113.5% of flowCommon StockSEC:0001562180-21-003230:0
12 of 12 declarations
About Cole Jason
Jason Cole is Chief Operating Officer and Chief Business Officer at bluebird bio, Inc. He plays a vital role in managing the operations and business development of the company, which focuses on gene therapies.
